This article has been updated with information from Roche's earnings call.

NEW YORK (GenomeWeb) – Roche today reported a 7 percent increase in molecular diagnostics sales for the first nine months of 2015, driven by virology testing, HPV screening, and noninvasive prenatal testing.

Overall, the company booked CHF 35.53 billion ($36.57 billion) in sales for the period, a two percent increase over the CHF 34.76 billion in sales for the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.